VMP 41792011000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Methotrexate 2.5mg tablets
BNF code 1001030U0AAABAB
Virtual Therapeutic Moiety Methotrexate
Date identifier became valid 12 May 2023
Previous product identifier 326874007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Methotrexate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Maxtrex 2.5mg tablets (Pfizer Ltd)
Methotrexate 2.5mg tablets (A A H Pharmaceuticals Ltd)
Methotrexate 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Methotrexate 2.5mg tablets (Almus Pharmaceuticals Ltd)
Methotrexate 2.5mg tablets (Cipla EU Ltd)
Methotrexate 2.5mg tablets (Medihealth (Northern) Ltd)
Methotrexate 2.5mg tablets (Morningside Healthcare Ltd)
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
Methotrexate 2.5mg tablets (Sandoz Ltd)
Methotrexate 2.5mg tablets (Sigma Pharmaceuticals Plc)
Methotrexate 2.5mg tablets (Sigma Pharmaceuticals Plc)
Methotrexate 2.5mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Methotrexate 2.5mg tablets 100 tablet
Methotrexate 2.5mg tablets 24 tablet
Methotrexate 2.5mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_1.1.0_20250106000001, imported on 7th January 2025 at 03:56:45.

Feedback